Cell Culture Market Worth 18.63 Billion USD by 2020

USA - English

• India - English

PUNE, India, February 22, 2016 /PRNewswire/ --

According to a new market research report " Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020", The global cell culture market is expected to reach USD 18,630.7 Million by 2020 from USD 11,310.9 Million in 2015, at a CAGR of 10.5% during the forecast period.

Browse 232 market data Tables and 57 Figures spread through 264 Pages and in-depth TOC on "Cell Culture Market"

http://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

Early buyers will receive 10% customization on this report. 

Cell Culture Market, by Equipment [Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)], Consumables (FBS, ABS, Media, Reagents), Application (Therapeutic, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

The report segments the cell culture market based on product, application, end user, and region. On the basis of products, the cell culture market is segmented into instruments and consumables. The instruments market is further segmented into bioreactors, cell culture vessels, cell culture storage equipment, and cell culture supporting instruments. The consumables market is further categorized into sera, media, and reagents; and bioreactor accessories. The consumables segment is expected to account for the largest share of the cell culture market in 2015.

Factors such as the increasing incidence of chronic diseases, increasing regulatory approvals for cell culture-based vaccines, increasing demand for mAbs, funding for cell-based research, growing use of single-use technologies, and technological advancements in cell culture products are driving the growth of the cell culture market during the forecast period.

Among end users, the pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. On the basis of region, the cell culture market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2015. However, the Asian market is expected to grow at the highest CAGR, mainly due to favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian economies.

Inquiry before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=559

The Cell Culture Market is highly competitive, encompassing a range of major as well as emerging players. Key market players Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Merck KGaA (Germany), Sartorius AG (Germany), Eppendorf AG (Germany), Lonza AG (Switzerland), Corning, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Promocell GmbH (Germany), and Hi-Media Laboratories (India).

Browse Related Reports: 

Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020.

http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application (Bioprodcution, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019.

http://www.marketsandmarkets.com/Market-Reports/cell-line-development-market-152900899.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets